AstraZeneca: Clinical Trials & Research Profile

Biopharma Industry (Cambridge, UK / Wilmington, DE) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Cambridge, UK / Wilmington, DE)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies300 active (134 recruiting now)
Total Tracked Studies (2018 to 2026)534 (330 with California sites)
Completed vs Early-Stopped Studies175 completed / 59 stopped (11.1% stop rate)
Median Closed Enrollment181 participants
FDA Drugs@FDA Original Approvals81 all-time (21 from 2018 to 2026)
Physical Hospital Site Disclosure0.9% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for AstraZeneca across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk